Bull & Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the bull's asymmetry case (a 7.8× P/E on a 58% Kazakhstan-only ROE, with three independent post-Culper credibility events already on the tape) is the stronger weight-of-evidence read, but the bear owns the single most consequential disclosure event: the FY2025 NPL coverage trajectory and the first Section 404(b) auditor attestation, both of which test the load-bearing claim of the entire equity story.

The decisive tension is credit quality vs the data-flywheel narrative: NPL coverage has fallen 99% → 90% → 80% over three years even as reported Cost of Risk stayed benign at 2.2% (FY2025) and 0.7% (Q1-26). One of those two readings is wrong. The next interim disclosure plus the Section 404(b) opinion will settle it. Until that lands, the right action is to lean long on the asymmetry but size to survive a credit print that confirms the bear.

Bull Case

Bull's price target is $165 per ADS (~78% upside from $92.85 on 26-May-2026), built from a re-rating from 7.8× to 13× on FY2026E underlying earnings of ~$2.4B — still a 40% discount to NU and 70% discount to MELI. Timeline is 18 months, covering the March 2027 20-F, the Rabobank A.Ş. closing, HEPS Adj-EBITDA breakeven validation, and the most probable NBK rate-cut window. The disconfirming signal Bull will accept: Kazakhstan Cost of Risk drifts above 3.0% for two consecutive quarters (vs FY2025 baseline 2.2%, Q1-26 0.7%) — the underwriting moat would be visibly cracking. (The bull's fourth point — credibility re-rating in motion via class-action dismissal, IG bond 3.5× oversubscribed, Tencent stake — was dropped as the weakest because it documents sentiment improvement rather than a structural earnings driver.)

Bear Case

Bear's downside target is ~$60 per ADR (~₸31,300; ~$11.5B market cap), ~33% below the 26-May-2026 close of $92.85. Method: peer multiple compression to ~5.5× P/E (Halyk / Brazilian-acquirer range) on stressed FY2026 IFRS NI of ~₸1,050B with incremental ₸89B ECL provision, the legislated +200 bps KZ bank-tax step-up, NIM compression, and a ~₸100B partial HEPS goodwill impairment. Timeline 12-18 months. Primary trigger: 1H 2026 (or FY2026) NPL coverage at/below 80% with CoR above 2.5%, and/or HEPS goodwill impairment ≥₸50B in interim accounts. Cover signal: first Section 404(b) attestation clean for FY2025 and NPL coverage rebuilds above 90% in 1H 2026 — both close the ECL-model concern that anchors the short. (The bear's fourth point — the unrebutted Culper allegation file as a "bear's free roll" into a thin float — was dropped as weakest because it depends on an unscheduled hypothetical second short report rather than a dated, observable disclosure event.)

The Real Debate

Verdict

Lean Long, Wait For Confirmation. The bull carries more weight on business quality — a 58% Kazakhstan-only ROE on a 93% retail-tenge deposit-funded book is a structurally rare asset, and three independent post-Culper credibility events (class action dismissed, IG bond 3.5× oversubscribed at Baa3/BBB−, Tencent strategic stake) have already begun to compress the country discount that explains most of the gap to NU. The decisive tension is the NPL coverage vs Cost-of-Risk divergence: coverage fell 99% → 90% → 80% while CoR was 0.7% in Q1-26 — one reading is wrong, and which one settles the data-flywheel debate that anchors the equity story. The bear could still be right because the FY23 ICFR material weakness sat in the ECL model and the first Section 404(b) auditor attestation has not yet landed. The durable thesis-breaker is a Section 404(b) qualified opinion plus NPL coverage staying at/below 80% with CoR drifting above 2.5%; the nearer-term evidence marker is the 1H 2026 interim disclosure on NPL coverage and any HEPS goodwill impairment. Until those land, the right read is to underwrite the asymmetry while sizing to survive a confirmed credit print.